Itex Olmesartan Plus Tablet 20/12.5 mg

Adult dose

This medication is administered once daily, one tablet at any time with or without meals. The dosage should be adjusted at intervals of 2 to 4 weeks based on the patient's blood pressure response. Elderly patients should start at the lowest dose, and caution is required when adjusting the dose considering renal function, cardiac function, comorbidities, and concomitant medications.

Child dose

Safety and efficacy in pediatric patients have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by patients who are allergic to any of the components, or have specific kidney and liver diseases, electrolyte imbalances, or certain genetic disorders. Patients with reduced blood volume, impaired kidney function, liver disease, or heart disease should use this medication with special caution and be closely monitored. As this medication lowers blood pressure, symptoms of hypotension may appear early in treatment, requiring appropriate measures. During treatment, electrolyte levels in the blood and kidney function should be regularly monitored, especially for changes in potassium levels. Side effects such as dizziness, headaches, indigestion, blood pressure fluctuations, and skin rashes may occur, and immediate consultation with healthcare professionals is necessary if severe side effects arise. Interactions may occur when taken with other medications, so it is essential to inform healthcare providers of any other medications being used, as adjustments may be needed. Pregnant or breastfeeding women should consider the potential impact on the fetus or infant and decide on the use of this medication after consulting with healthcare professionals. In the case of elderly patients and children, the safety and efficacy of this medication have not been sufficiently established, and caution is advised during administration. Overdosing may cause symptoms such as hypotension, electrolyte imbalances, and dehydration, so immediate medical attention is necessary if symptoms occur. During treatment, caution is required during activities such as driving or operating machinery, and activities should be limited if severe symptoms arise. Long-term use may increase the risk of skin cancer, so it is advisable to avoid sun exposure and regularly check skin condition.

Serious side effects

Urticaria, angioedema, anaphylactic reaction, severe swelling (edema), urticaria, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, difficulty breathing, respiratory distress, asthma attacks, respiratory difficulties accompanying cough and fever, jaundice of the skin or eyes, extreme fatigue, liver abnormalities (jaundice), sudden and severe headache, seizures, loss of consciousness

Mild side effects

Nausea, metabolic abnormalities (hyperuricemia, hyperglycemia, hyperlipidemia, hyperkalemia, hypokalemia, hyponatremia, hypomagnesemia, hypochloremic alkalosis, hypercalcemia), dizziness, headaches, lightheadedness, palpitations, abdominal pain, indigestion, gastritis, diarrhea, vomiting, thirst, abdominal discomfort, constipation, sialadenitis, dry mouth, gastric pain, cough, upper respiratory infection, hematuria, peripheral edema, facial swelling, increased blood pressure, pruritus,

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture. It is essential to store it in a cool place, between 1 to 25 degrees Celsius, to maintain its efficacy.

Appearance

Round film-coated tablet with a reddish-yellow color

Package unit

30 tablets/bottle, 200 tablets/bottle, 300 tablets/bottle